The American Conference Institute (ACI) is proud to announce that its industry leading FDA Boot Camp conference is returning to Boston on September 13-15, 2017. Over the past 12 years, thousands of legal professionals – from associates to partners to GCs – have relied on ACI’s FDA Boot Camp to provide them with both a…
Complimentary Webinar Register to the Webinar Now Subject: BPCIA Update: The 180-day Notice of Commercial Marketing in the Courts Date/Time: Thursday, April 28 1:00 pm – 2:00 pm EST, 12:00 pm – 1:00 pm CST, 10:00 am – 11:00 am PST Featured Panelists: Mark I. Bowditch Mark Bowditch Vice President, Intellectual Property and Litigation…
NEW YORK – March 21, 2016 – American Conference Institute (ACI) is pleased to announce that some of the Food and Beverage Industry’s largest companies will be sending their senior legal representatives to ACI’s 6th Advanced Regulatory and Compliance Summit on Food & Beverage Marketing and Advertising conference, which will take place at the Omni Chicago on May 10-12,…
Published on Drug and Device Law on December 15, 2015 We learned about it yesterday from a reporter, but were sworn to secrecy until today. Pacira Pharmaceuticals and the FDA settled their litigation with Pacira getting essentially everything it wanted – what the company calls “favorable resolution.” Pursuant to the settlement agreement, the FDA is formally rescinding its unfortunate warning letter that…
Press Release Published by ICMAD on November 19, 2015 The Independent Cosmetic Manufacturers and Distributors (ICMAD) association is proud to support legislation introduced today by U.S. Congressman Pete Sessions (R-TX), H.R.4075, The Safe Cosmetics Modernization Act. H.R.4075 modernizes and improves the Food and Drug Administration’s ability to assure the safety of cosmetic products by examining ingredient safety, establishing…
Complimentary presentation from ACI’s 23rd FDA Boot camp. Highlights from this presentation: – FDA’s GMP philosophy – Substantive drug areas – Sources of GMPs – FDA Inspection triggers – Typical investigation activities and much more…
When: Wednesday, June 04 to Friday, June 06, 2014 Where: InterContinental New York Barclay, New York, NY To learn more, visit: AmericanConference.com/biosimilars
by Jordan Grotzinger, Originally Published on consumerproductscounselor.com California isn’t exactly known as a business-friendly state. In some ways, the governor has tried to change that. He’ll have an interesting choice to make if a recently-passed senate bill reaches his desk.
Pharma & Healthcare – the latest on Pfizer Inc v. Teva Pharmaceuticals, the USFDA imposes penalties on Indian pharma cos’ and more. FDA panel could give Bayer painkiller an edge over rivals from Pfizer, J&J by Tracy Staton Published on FiercePharma.com What if every drug in a class posed a risk to the heart–all except one?…
Expert Guest Entry by Bill Marler, Originally Posted on MarlerBlog From our good friends at the FDA: Following actions by the Food and Drug Administration (FDA), a Texas-based company has agreed to recall and destroy a dietary supplement linked to dozens of cases of acute liver failure and hepatitis, including one death and illnesses so severe that several patients…
Join Our Mailing List
Receive exclusive discounts, offers and agenda updates directly to your inbox.
We use technologies like cookies to store and/or access device information. We do this to improve browsing experience and to show (non-) personalized ads. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.